{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:54:26Z","timestamp":1785275666788,"version":"3.55.0"},"reference-count":49,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.3201\/eid2502.181326","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T18:44:44Z","timestamp":1547577884000},"page":"290-298","source":"Crossref","is-referenced-by-count":38,"title":["Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1"],"prefix":"10.3201","volume":"25","author":[{"given":"Anita K.","family":"McElroy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punya","family":"Shrivastava-Ranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"Harmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roosecelis B.","family":"Martines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Silva-Flannery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Flietstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen S.","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneesh K.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Marshall","family":"Lyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay B.","family":"Varkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce S.","family":"Ribner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart T.","family":"Nichol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif R.","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina F.","family":"Spiropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2502.181326-201901151343-R1","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1016\/S0002-9440(10)63592-4","article-title":"Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells.","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am J Pathol"},{"key":"key-10.3201\/eid2502.181326-201901151343-R2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/path.4456","article-title":"Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses.","volume":"235","author":"Martines","year":"2015","journal-title":"J Pathol"},{"key":"key-10.3201\/eid2502.181326-201901151343-R3","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/infdis\/jiu088","article-title":"Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome.","volume":"210","author":"McElroy","year":"2014","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2502.181326-201901151343-R4","doi-asserted-by":"publisher","first-page":"e837","DOI":"10.1371\/journal.pntd.0000837","article-title":"Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis.","volume":"4","author":"Wauquier","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.3201\/eid2502.181326-201901151343-R5","doi-asserted-by":"publisher","first-page":"S357","DOI":"10.1086\/520611","article-title":"Cytokine and chemokine expression in humans infected with Sudan Ebola virus.","volume":"196","author":"Hutchinson","year":"2007","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2502.181326-201901151343-R6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1046\/j.1365-2249.2002.01800.x","article-title":"Inflammatory responses in Ebola virus-infected patients.","volume":"128","author":"Baize","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"key-10.3201\/eid2502.181326-201901151343-R7","doi-asserted-by":"publisher","first-page":"S188","DOI":"10.1086\/514283","article-title":"Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection.","volume":"179","author":"Villinger","year":"1999","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2502.181326-201901151343-R8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fmed.2015.00004","article-title":"Ebola virus disease has features of hemophagocytic lymphohistiocytosis syndrome.","volume":"2","author":"van der Ven","year":"2015","journal-title":"Front Med (Lausanne)"},{"key":"key-10.3201\/eid2502.181326-201901151343-R9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/JBM.S46255","article-title":"Hemophagocytic lymphohistiocytosis: review of etiologies and management.","volume":"5","author":"George","year":"2014","journal-title":"J Blood Med"},{"key":"key-10.3201\/eid2502.181326-201901151343-R10","doi-asserted-by":"publisher","first-page":"e64921","DOI":"10.1371\/journal.pone.0064921","article-title":"Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010.","volume":"8","author":"Dowd","year":"2013","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2502.181326-201901151343-R11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/ajh.20969","article-title":"Crimean-Congo hemorrhagic fever: five patients with hemophagocytic syndrome.","volume":"83","author":"Tasdelen Fisgin","year":"2008","journal-title":"Am J Hematol"},{"key":"key-10.3201\/eid2502.181326-201901151343-R12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jcv.2015.06.004","article-title":"Dengue infection associated hemophagocytic syndrome: Therapeutic interventions and outcome.","volume":"69","author":"Wan Jamaludin","year":"2015","journal-title":"J Clin Virol"},{"key":"key-10.3201\/eid2502.181326-201901151343-R13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy.","volume":"12","author":"Grom","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"key-10.3201\/eid2502.181326-201901151343-R14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7150\/ijms.13680","article-title":"Macrophage activation syndrome-associated markers in severe dengue.","volume":"13","author":"Ab-Rahman","year":"2016","journal-title":"Int J Med Sci"},{"key":"key-10.3201\/eid2502.181326-201901151343-R15","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1073\/pnas.1502619112","article-title":"Human Ebola virus infection results in substantial immune activation.","volume":"112","author":"McElroy","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2502.181326-201901151343-R16","doi-asserted-by":"publisher","first-page":"e00845-17","DOI":"10.1128\/mBio.00845-17","article-title":"Ebola virus binding to TIM-1 on T lymphocytes induces a cytokine storm.","volume":"8","author":"Younan","year":"2017","journal-title":"MBio"},{"key":"key-10.3201\/eid2502.181326-201901151343-R17","doi-asserted-by":"publisher","first-page":"e00179-17","DOI":"10.1128\/JVI.00179-17","article-title":"Ebolaviruses associated with differential pathogenicity induce distinct host responses in human macrophages.","volume":"91","author":"Olejnik","year":"2017","journal-title":"J Virol"},{"key":"key-10.3201\/eid2502.181326-201901151343-R18","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/cid\/ciw334","article-title":"Kinetic analysis of biomarkers in a cohort of US patients with Ebola virus disease.","volume":"63","author":"McElroy","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2502.181326-201901151343-R19","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1128\/JCM.30.4.947-950.1992","article-title":"Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates.","volume":"30","author":"Ksiazek","year":"1992","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2502.181326-201901151343-R20","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1086\/514319","article-title":"A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epid\u00e9mies \u00e0 Kikwit.","volume":"179","author":"Zaki","year":"1999","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2502.181326-201901151343-R21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/bjh.12138","article-title":"Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis.","volume":"160","author":"Lehmberg","year":"2013","journal-title":"Br J Haematol"},{"key":"key-10.3201\/eid2502.181326-201901151343-R22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"key-10.3201\/eid2502.181326-201901151343-R23","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/art.39332","article-title":"2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation collaborative initiative.","volume":"68","author":"Ravelli","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"key-10.3201\/eid2502.181326-201901151343-R24","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1056\/NEJMoa1504874","article-title":"Clinical management of Ebola virus disease in the United States and Europe.","volume":"374","author":"Uyeki","year":"2016","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2502.181326-201901151343-R25","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/S1473-3099(15)00144-9","article-title":"Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study.","volume":"15","author":"Hunt","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2502.181326-201901151343-R26","first-page":"657","article-title":"Plasma ferritin determination as a diagnostic tool.","volume":"145","author":"Finch","year":"1986","journal-title":"West J Med"},{"key":"key-10.3201\/eid2502.181326-201901151343-R27","doi-asserted-by":"publisher","first-page":"e0005645","DOI":"10.1371\/journal.pntd.0005645","article-title":"Different features of V\u03b42 T and NK cells in fatal and non-fatal human Ebola infections.","volume":"11","author":"Cimini","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.3201\/eid2502.181326-201901151343-R28","doi-asserted-by":"publisher","first-page":"S364","DOI":"10.1086\/520613","article-title":"Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus.","volume":"196","author":"Rollin","year":"2007","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2502.181326-201901151343-R29","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1056\/NEJMoa1411677","article-title":"A case of severe Ebola virus infection complicated by gram-negative septicemia.","volume":"371","author":"Kreuels","year":"2014","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2502.181326-201901151343-R30","doi-asserted-by":"publisher","first-page":"S275","DOI":"10.1093\/infdis\/jiw260","article-title":"Ebola virus disease is characterized by poor activation and reduced levels of circulating CD16+ monocytes.","volume":"214","author":"L\u00fcdtke","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2502.181326-201901151343-R31","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature17949","article-title":"Unique human immune signature of Ebola virus disease in Guinea.","volume":"533","author":"Ruibal","year":"2016","journal-title":"Nature"},{"key":"key-10.3201\/eid2502.181326-201901151343-R32","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/art.22416","article-title":"The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor \u03b1-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.","volume":"56","author":"Bleesing","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key-10.3201\/eid2502.181326-201901151343-R33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1600-0609.2004.00318.x","article-title":"Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome.","volume":"74","author":"Schaer","year":"2005","journal-title":"Eur J Haematol"},{"key":"key-10.3201\/eid2502.181326-201901151343-R34","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1097\/DAD.0000000000000825","article-title":"Role of skin biopsies in the diagnosis of hemophagocytic lymphohistiocytosis.","volume":"39","author":"Santos-Arroyo","year":"2017","journal-title":"Am J Dermatopathol"},{"key":"key-10.3201\/eid2502.181326-201901151343-R35","doi-asserted-by":"publisher","first-page":"e112127","DOI":"10.1371\/journal.pone.0112127","article-title":"Elevated soluble CD163 plasma levels are associated with disease severity in patients with hemorrhagic fever with renal syndrome.","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2502.181326-201901151343-R36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00002371-199202000-00005","article-title":"Serum CD25 levels during interleukin-2 therapy: dose dependence and correlations with clinical toxicity and lymphocyte surface sCD25 expression.","volume":"11","author":"Bogner","year":"1992","journal-title":"J Immunother (1991)"},{"key":"key-10.3201\/eid2502.181326-201901151343-R37","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.coviro.2018.01.010","article-title":"Immune barriers of Ebola virus infection.","volume":"28","author":"McElroy","year":"2018","journal-title":"Curr Opin Virol"},{"key":"key-10.3201\/eid2502.181326-201901151343-R38","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/imj.12768","article-title":"Conditions associated with extreme hyperferritinaemia (>3000\u2009\u03bcg\/L) in adults.","volume":"45","author":"Wormsbecker","year":"2015","journal-title":"Intern Med J"},{"key":"key-10.3201\/eid2502.181326-201901151343-R39","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1182\/blood-2009-11-253815","article-title":"Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway.","volume":"116","author":"Cohen","year":"2010","journal-title":"Blood"},{"key":"key-10.3201\/eid2502.181326-201901151343-R40","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/SHK.0b013e31829266b9","article-title":"Ferritin L is the sole serum ferritin constituent and a positive hepatic acute-phase protein.","volume":"39","author":"Naz","year":"2013","journal-title":"Shock"},{"key":"key-10.3201\/eid2502.181326-201901151343-R41","first-page":"66","article-title":"Beneficial effects of cytokine induced hyperlipidemia.","volume":"37","author":"Feingold","year":"1998","journal-title":"Z Ernahrungswiss"},{"key":"key-10.3201\/eid2502.181326-201901151343-R42","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/infdis\/jiw263","article-title":"Plasma soluble CD163 level independently predicts all-cause mortality in HIV-1\u2013infected individuals.","volume":"214","author":"Knudsen","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2502.181326-201901151343-R43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1189\/jlb.1205756","article-title":"Pivotal advance: activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163.","volume":"80","author":"Weaver","year":"2006","journal-title":"J Leukoc Biol"},{"key":"key-10.3201\/eid2502.181326-201901151343-R44","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1189\/jlb.72.4.711","article-title":"Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163.","volume":"72","author":"Hintz","year":"2002","journal-title":"J Leukoc Biol"},{"key":"key-10.3201\/eid2502.181326-201901151343-R45","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/sji.12468","article-title":"Macrophage phenotype in liver injury and repair.","volume":"85","author":"Sun","year":"2017","journal-title":"Scand J Immunol"},{"key":"key-10.3201\/eid2502.181326-201901151343-R46","doi-asserted-by":"publisher","first-page":"e80908","DOI":"10.1371\/journal.pone.0080908","article-title":"Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages.","volume":"8","author":"Barros","year":"2013","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2502.181326-201901151343-R47","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1006\/viro.2001.0836","article-title":"Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1\u03b1 and TNF-\u03b1 and inhibit poly-IC-induced IFN-\u03b1 in vitro.","volume":"284","author":"Gupta","year":"2001","journal-title":"Virology"},{"key":"key-10.3201\/eid2502.181326-201901151343-R48","doi-asserted-by":"publisher","first-page":"11025","DOI":"10.1128\/JVI.75.22.11025-11033.2001","article-title":"Infection and activation of monocytes by Marburg and Ebola viruses.","volume":"75","author":"Str\u00f6her","year":"2001","journal-title":"J Virol"},{"key":"key-10.3201\/eid2502.181326-201901151343-R49","doi-asserted-by":"publisher","first-page":"e00226-17","DOI":"10.1128\/mBio.00226-17","article-title":"The toll-like receptor receptor 4 antagonist eritoran protects mice from lethal filovirus challenge","volume":"8","author":"Younan","year":"2017","journal-title":"MBio"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/25\/2\/18-1326_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:27:28Z","timestamp":1732987648000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/25\/2\/18-1326_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2502.181326","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}